Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Natalizumab 300mg/15ml solution for infusion vials |
| BNF code | 0802040W0AAAAAA |
| Virtual Therapeutic Moiety | Natalizumab |
| Date identifier became valid | 29 Oct 2018 |
| Previous product identifier | 414806008 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Date of name applicability | 19 Jan 2009 |
| Previous name | Natalizumab 300mg/15ml solution for injection vials |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 15.000 |
| Unit dose form units | ml |
| Unit dose unit of measure | vial |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Natalizumab |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 20.000 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | solutioninfusion.intravenous |
| Dose Form | |
| Formulation | Solution for infusion |
| Drug Route | |
| Route | Intravenous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Tyruko 300mg/15ml concentrate for solution for infusion vials (Sandoz Ltd) | |
| Tysabri 300mg/15ml concentrate for solution for infusion vials (Biogen Idec Ltd) | |
| Virtual Medicinal Product Packs | |
| Natalizumab 300mg/15ml solution for infusion vials 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_5.2.0_20240520000001, imported on 20th May 2024 at 05:03:18.